These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3774839)

  • 1. PAF and leukotrienes '85. Proceedings of the meeting. Paris, September 27th 1985.
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():1-242. PubMed ID: 3774839
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether.
    Goldstein RE; Ezra D; Laurindo FR; Feuerstein GZ
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():151-62. PubMed ID: 3774842
    [No Abstract]   [Full Text] [Related]  

  • 3. The causal role of PAF and leukotrienes in acute cardiac allograft rejection in rats.
    Foegh ML; Khirabadi BS; Rowles JR; Braquet P; Ramwell PW
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():127-32. PubMed ID: 3534895
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma.
    Page CP; Morley J
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():217-37. PubMed ID: 3774847
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of leukotrienes and PAF-acether electrophysiological activity of the rat retina.
    Doly M; Braquet P; Bonhomme B; Meyniel G
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():201-8. PubMed ID: 3022310
    [No Abstract]   [Full Text] [Related]  

  • 6. PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986.
    Agents Actions Suppl; 1987; 21():1-260. PubMed ID: 3478993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids].
    Hemmendinger S; d'Humières S; Russo-Marie F; Cazenave JP
    Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():29-36. PubMed ID: 3938941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and peptide mediators of inflammation. Summary.
    Goetzl EJ; Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3119. PubMed ID: 6313434
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a case for PAF-acether antagonists? Institut Pasteur, Paris, 21 June 1985. Abstracts.
    Prostaglandins; 1985 Oct; 30(4):683-729. PubMed ID: 4081064
    [No Abstract]   [Full Text] [Related]  

  • 12. 1st International Symposium on Platelet-Activating Factor (PAF-ACETHER, AGEPC) and structurally related ether-lipids. Paris (France) June 26-29, 1983. Abstracts.
    J Pharmacol; 1983; 14 Suppl 1():1-104. PubMed ID: 6876807
    [No Abstract]   [Full Text] [Related]  

  • 13. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of platelet-activating factor in the mammalian female reproductive tract.
    Tiemann U
    Reprod Domest Anim; 2008 Dec; 43(6):647-55. PubMed ID: 18363604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A bioregulator of lipid nature--a platelet activating factor (PAF)].
    Gordeev KIu; Serebrennikova GA; Evstigneeva RP
    Bioorg Khim; 1984 Dec; 10(12):1589-605. PubMed ID: 6099122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators and asthma.
    Barnes PJ
    Br J Hosp Med; 1985 Dec; 34(6):339-44. PubMed ID: 3936563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
    Sturk A; Schaap MC; ten Cate JW; Heymans HS; Schutgens RB; Przyrembel H; Borst P
    J Clin Invest; 1987 Feb; 79(2):344-50. PubMed ID: 3805272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC; Szpejda M
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-activating factor in reproduction: sperm function.
    Roudebush WE
    Asian J Androl; 2001 Jun; 3(2):81-5. PubMed ID: 11404790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
    Graham RM; Strahan ME; Norman KW; Watkins DN; Sturm MJ; Taylor RR
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.